Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.32), $0.56 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.